GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (MEX:NVS N) » Definitions » EV-to-Revenue

Novartis AG (MEX:NVS N) EV-to-Revenue : 5.16 (As of Dec. 14, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Novartis AG EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Novartis AG's enterprise value is MXN4,625,945 Mil. Novartis AG's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was MXN896,212 Mil. Therefore, Novartis AG's EV-to-Revenue for today is 5.16.

The historical rank and industry rank for Novartis AG's EV-to-Revenue or its related term are showing as below:

MEX:NVS N' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.22   Med: 4.3   Max: 5.25
Current: 4.39

During the past 13 years, the highest EV-to-Revenue of Novartis AG was 5.25. The lowest was 3.22. And the median was 4.30.

MEX:NVS N's EV-to-Revenue is ranked worse than
69.42% of 994 companies
in the Drug Manufacturers industry
Industry Median: 2.495 vs MEX:NVS N: 4.39

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-14), Novartis AG's stock price is MXN2138.50. Novartis AG's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was MXN437.42. Therefore, Novartis AG's PS Ratio for today is 4.89.


Novartis AG EV-to-Revenue Historical Data

The historical data trend for Novartis AG's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG EV-to-Revenue Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.49 4.57 4.27 4.36 4.57

Novartis AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.64 4.57 4.57 4.92 4.81

Competitive Comparison of Novartis AG's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Novartis AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Novartis AG's EV-to-Revenue falls into.



Novartis AG EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Novartis AG's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4625945.165/896212.353
=5.16

Novartis AG's current Enterprise Value is MXN4,625,945 Mil.
Novartis AG's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN896,212 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis AG  (MEX:NVS N) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Novartis AG's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2138.50/437.422
=4.89

Novartis AG's share price for today is MXN2138.50.
Novartis AG's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN437.42.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis AG EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Novartis AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines